Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-19-054773

Director sold 21,000 shares at $51.89 ($1,089,675)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2019-10-30 Sale −21,000 $51.89 $1,089,675 13,745 D
Open-market sales · 21,000 sh · avg $51.89 · $1,089,675
Loading xslF345X03/doc4.xml…